Email this article Significance of antibacterial therapy of Chlamydophila pneumoniae infection in patients with bronchial asthma
- Authors: Khamitov RF1, Palmova LY.2, Novozhenov VG3
-
Affiliations:
- Казанский государственный медицинский университет МЗ и СР РФ
- Стационар дневного пребывания Пульмонологическогоцентра Казани
- Государственный институт усовершенствования врачей Министерства обороны РФ
- Issue: Vol 79, No 10 (2004)
- Pages: 91-93
- Section: Editorial
- URL: https://journal-vniispk.ru/0040-3660/article/view/29953
- ID: 29953
Cite item
Full Text
Abstract
Aim. To study effects of eradication of Chlamydophila pneumoniae CP) infection in bronchial asthma
(BA) on BA course and changes in quality of life (QOL) in BA patients.
Material and methods. 194 BA patients in clinical remission participated in the trial. Microbiological
diagnosis of asymptomatic CP infection was made serologically (ELISA, indirect enzyme immunoassay) using polymerase chain reaction. Clinical and biochemical tests, assessment of pulmonary
ventilation function, QOL by AQLQ during 6-week antimicrobial therapy were made in 56patients.
Results. Patients with stable BA had high frequency of serological signs of clinically asymptomatic CP
infection (52%) deteriorating BA symptoms and QOL. Antibacterial therapy of latent CP infection
with azitromycin significantly improved BA course and QOL ofBA patients.
Conclusion. When laboratory tests detect CP infection in patients with long-term course of BA, especially in smoking males with moderate and severe BA it is clinically valid to prescribe addition of azitromycin to basic antiinflammatory treatment of BA.
(BA) on BA course and changes in quality of life (QOL) in BA patients.
Material and methods. 194 BA patients in clinical remission participated in the trial. Microbiological
diagnosis of asymptomatic CP infection was made serologically (ELISA, indirect enzyme immunoassay) using polymerase chain reaction. Clinical and biochemical tests, assessment of pulmonary
ventilation function, QOL by AQLQ during 6-week antimicrobial therapy were made in 56patients.
Results. Patients with stable BA had high frequency of serological signs of clinically asymptomatic CP
infection (52%) deteriorating BA symptoms and QOL. Antibacterial therapy of latent CP infection
with azitromycin significantly improved BA course and QOL ofBA patients.
Conclusion. When laboratory tests detect CP infection in patients with long-term course of BA, especially in smoking males with moderate and severe BA it is clinically valid to prescribe addition of azitromycin to basic antiinflammatory treatment of BA.
About the authors
R F Khamitov
Казанский государственный медицинский университет МЗ и СР РФКазанский государственный медицинский университет МЗ и СР РФ
L Yu Palmova
Стационар дневного пребывания Пульмонологическогоцентра КазаниСтационар дневного пребывания Пульмонологическогоцентра Казани
V G Novozhenov
Государственный институт усовершенствования врачей Министерства обороны РФГосударственный институт усовершенствования врачей Министерства обороны РФ
References
- El-Halees W., Solis R., Khan M. A. The role of recent Mycoplasma pneumoniae infection in acute exacerbation of bronchial asthma. In: The 96th International conferences of American Thoracic Society: Poster. Toronto; 2000. 143.
- Szulakowski P., Friedek D., Ekiel A. et al. Microbiological analysis of the occurrence of respiratory tract pathogens in pa tients with bronchial asthma. In: The European Respiratory Society. Annual congress: Abstracts. Stockholm; 2002. 2708.
- Foy H. M. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin. Infect. Dis. 1993; 17 (suppl. 1): 37-46.
- Dakhamo A., Martin R. J., Gelfand E. W. Effects of Mycoplasma pneumoniae infection on airway epithelial cell function in vitro. In: The 97th International conferences of American Thoracic Society. Poster. San Francisco; 2001: 909.
- Kothe H., Rupp J., Muller F. et al. Chlamydia pneumoniae inhibits the apoptosis of infected human neutrophils. In: The European Respiratory Society. Annual congress. Abstracts. Berlin; 2001. 2019.
- Cook P. J., Honeybourne D. Clinical aspects of Chlamydia pneumoniae infection. Press. Med. 1995; 24 (5): 278-282.
- Hahn D. L., Bukstein D., Luskin A., Zeitz H. Evidence for Chlamydia pnyumoniae infection in steroid-dependent asthma. Ann. Allergy Asthma Immunol. 1998; 80 (1): 45-49.
- Emre U., Bernius M., Roblin P. M. et al. Chlamydia pneumoniae infection in patients with cystic fobrosis. Clin. Infect. Dis. 1996; 22 (5): 819-823.
- Hahn D. L. Treatment of Chlamydia pneumoniae infection in adult asthma: a beforeafter trial. J. Fam. Pract. 1995; 41 (4): 345-351.
- Чучалин А. Г. (ред.) Глобальная стратегия лечения и профилактики бронхиальной астмы. М.: Изд-во "Атмосфера"; 2002.
- Bjomsson E., Hjelm E., Janson С. et al. Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness. Scand. 3. Infect. Dis. 1996; 28 (1): 63-69.
- Spahn J. D. Clarithromycin may have an anti-inflammatory effect in asthma. Ann. Allergy Asthma Immunol. 2001; 87: 501- 505.
Supplementary files
